Alx Oncology Holdings (ALXO) Asset Utilization Ratio (2020 - 2021)

Alx Oncology Holdings (ALXO) reported Asset Utilization Ratio of 0.0 for Q1 2021, down 64.16% sequentially from 0.0 in Q4 2020.

Alx Oncology Holdings (ALXO) Asset Utilization Ratio (2020 - 2021) Analysis & Trends

Alx Oncology Holdings (ALXO) has 2 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q1 2021.

For the quarter ending Q1 2021, Asset Utilization Ratio changed N/A year-over-year to 0.0; the trailing twelve-month figure through Mar 2021 stood at 0.0 (changed N/A YoY), and the FY2020 full-year result was 0.01, changed N/A from the prior year.
Asset Utilization Ratio retreated to 0.0 in Q1 2021, from 0.0 in the prior quarter.
In the past five years, Asset Utilization Ratio ranged from a high of 0.01 in Q3 2020 to a low of 0.0 in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	0.69
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	0.47
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	0.37
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Alx Oncology Holdings	211.24 Mn	211.24 Mn	-	-

Download Data